Desai AS, Solomon DH, Stone PH, Avorn J Economic consequences of routine coronary angiography in low- and intermediate-risk patients with unstable angina pectoris. Am J Cardiol. 2003 Aug 15;92(4):363-7.
Detrano R, Gianrossi R, Froelicher V The diagnostic accuracy of the exercise electrocardiogram: a meta-analysis of 22 years of research. Prog Cardiovasc Dis. 1989 Nov-Dec;32(3):173-206.
Hollander JE, Litt HI, Chase M, Brown AM, Kim W, Baxt WG Computed tomography coronary angiography for rapid disposition of low-risk emergency department patients with chest pain syndromes. Acad Emerg Med. 2007 Feb;14(2):112-6.
Kline JA, Mitchell AM, Runyon MS, Jones AE, Webb WB Electronic medical record review as a surrogate to telephone follow-up to establish outcome for diagnostic research studies in the emergency department. Acad Emerg Med. 2005 Nov;12(11):1127-33. Epub 2005 Sep 15.
Manini AF, Gisondi MA, van der Vlugt TM, Schreiber DH Adverse cardiac events in emergency department patients with chest pain six months after a negative inpatient evaluation for acute coronary syndrome. Acad Emerg Med. 2002 Sep;9(9):896-902.
McCaig LF, Nawar EW National Hospital Ambulatory Medical Care Survey: 2004 emergency department summary. Adv Data. 2006 Jun 23;(372):1-29.
Sprivulis PC, Da Silva JA, Jacobs IG, Frazer AR, Jelinek GA The association between hospital overcrowding and mortality among patients admitted via Western Australian emergency departments. Med J Aust. 2006 Mar 6;184(5):208-12. Erratum in: Med J Aust. 2006 Jun 19;184(12):616.
Tsushima Y, Aoki J, Endo K Contribution of the diagnostic test to the physician's diagnostic thinking: new method to evaluate the effect. Acad Radiol. 2003 Jul;10(7):751-5.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
